Changes in Markers of Disease Progression in HIV-1 Seroconverters
Noya Galai(University of Haifa), Álvaro Muñoz(Johns Hopkins University), Neil M.H. Graham(Regeneron (United States)), Kan Chen, Joseph B. Margolick(Johns Hopkins University), David Vlahov(Yale University)
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
January 1, 1995
Cited by 41
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
|The Lancet|2002|1.1k
The Natural History of Hepatitis C Virus Infection
|JAMA|2000|1.1k
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|505